Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05386719 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cardiometabolic Screening Program

StatusRecruiting
PhaseNot applicable
Started2022-06-03
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Sep 1, 2026 → Aug 1, 2027
See other at-risk trials from Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Amendment history

2026-09-02
Study Status v7
Primary completion pushed: 2026-09-01 → 2027-08-01
2026-06-22
Study Status v6
Primary completion date2026-06-01→2026-09-01
Completion date2027-06-01→2027-08-01
2025-06-18
Study Status, Sponsor/Collaborators v5
Primary completion date2025-06-01→2026-06-01
Collaborators+27 characters
Private Philanthropic Funds
2024-06-17
2 amendments v3-v4
2 re-verifications since 2023-06-29, no change to tracked fields
2022-06-16
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2022-06-01→confirmed 2022-06-03
Study sites0→1
2022-05-24
Study Status, Outcome Measures v1
Secondary endpoints10 to 9 entries
Number of breast cancer patients with cardiovascular risk factors (obesity) Number of breast cancer patients with cardiovascularCardiovascular risk factors (tobacco use) Number of breast cancer patients with cardiovascularCardiovascular risk factors (family history) Number of breast cancer patients with cardiovascularCardiovascular risk factors (hypertension) Number of referralsReferrals for individuals with pre-diabetes Number of referralsReferrals for individuals with diabetes Number of referralsReferrals for individuals with risk of cardiovascular disease IncidencePrevalence of prediabetes [...] [...]
Primary endpoints8 entries, revised
ChangeBreast-specific in Body Mass Index (BMI) Change in Quality of Life assymptoms assessed by the Quality of Life Questionnaire C30 Change in Quality of Life as assessed by the The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire BR-23 Prevalence of obesity/ overweight Quality of Life Questionnaire The European Organisation for Research and Treatment Cancer C30
2022-05-18
Original filing
This research study is being done to implement a screening program for prediabetes, diabetes, dyslipidemia and/or hyperlipidemia, and higher risk of cardiovascular disease in breast cancer survivors. This program will also help to direct individuals with risk factors to community and institutional resources for management.
Trial Details
NCT Number NCT05386719
Lead Sponsor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators: Private Philanthropic Funds
Conditions Breast Cancer, Early-stage Breast Cancer
Enrollment 450 participants
Start Date 2022-06-03
Primary Completion 2027-08-01 (estimated)
Study Completion 2027-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-03